Browsing Tag
Sparian Biosciences
1 post
Could SBS-147 become a credible challenger to opioid-based pain management pathways?
Could SBS-147 challenge opioid-based pain treatment pathways? Read how Sparian Biosciences’ Phase 1 launch could reshape the non-opioid market.